Hwa Wen Lee

CEO, Action Against Age-Related Macular Degeneration (AAAMD)
$download_content = get_field('download_content');

Dr Lee is the CEO and Chief Scientist at Action Against Age-Related Macular Degeneration (AAAMD), a research charity focused on tackling the leading cause of
legal blindness in the developed world

Dr Lee is presently the CEO and Chief Scientist at Action Against Age-Related Macular Degeneration (AAAMD), a research charity focused on tackling the leading cause of legal blindness in developed world at its earliest stages with maximum affordability and accessibility.

He is also a co-director of Oxford Martin School’s Affordable Medicines Programme. Trained in genetics and molecular/ structural biology, he is an experienced leader in setting up partnerships and alliances with multiple stakeholders to accelerate discoveries for drug discovery.

Dr Lee designed and implemented several open science strategies in two of the largest and most successful international public-private partnerships for drug
discovery – the Structural Genomics Consortium (SGC) and the European Lead Factory.

Alongside his scientific endeavours, Dr Lee also advised high-level government representatives from different countries and charitable institutions on policy and strategy to integrate scientific, societal, and economic impact.

Presently, Lee is part of HDRUK INSIGHT Hub’s Leadership Team, leading the creation of its Data Trust Advisory Board (DataTAB) alongside ODI to bring in public and patients at Governance level for a transparent, fair and accountable use of health data.